Top compounds associated with response to HILPDA


Feature Type Standardized
Nominal ANOVA
mRNA Nilotinib CTRPv2 pan-cancer AAC -0.018 0.6
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.017 0.6
mRNA Erlotinib UHNBreast pan-cancer AAC 0.13 0.6
mRNA CAY10594 CTRPv2 pan-cancer AAC 0.018 0.6
mRNA isoliquiritigenin CTRPv2 pan-cancer AAC 0.03 0.7
mRNA SZ4TA2 CTRPv2 pan-cancer AAC 0.025 0.7
mRNA PF-750 CTRPv2 pan-cancer AAC 0.017 0.7
mRNA SGX-523 CTRPv2 pan-cancer AAC -0.017 0.7
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC 0.033 0.7
mRNA BRD-K51831558 CTRPv2 pan-cancer AAC 0.024 0.7
Download CSV